We can't find the internet
Attempting to reconnect
15807.1;9 PFLS-LS
Development of transducible artificial transcription factor therapeutics (TAFTs): A new generation of drugs for ophthalmic disorders.
Résumé
Development of transducible artificial transcription factor therapeutics (TAFTs): A new generation of drugs for ophthalmic disorders.
Textes supplémentaires
Abstract
The proposed CTI project aims to develop TAFTs for the treatment of ophthalmic diseases such as retinal vascular diseases, glaucoma and age-related macula degeneration. TAFTs are a new class of biologics modulating gene expression. They are designed to target expression of specific receptor proteins connected to the pathophysiology of eye diseases. The project is expected to bring TAFTs from the preclinical to the clinical stage, thus strenghening Aliophtha's TAFT pipeline.
Participants
Albert Neutzner
Kontaktperson
albert.neutzner@unibas.ch
University of Basel Albert Neutzner Hebelstrasse 20 4031 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2013-09-30
- Date de fin
- 2015-06-30
- Coûts totaux approuvés
- CHF 819287.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- T490 Biotechnology 100.0%